The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*
Abstract
There is increasing evidence of genetic contribution to the pathogenesis of Parkinson's disease. The identification of mutations in the leucine-rich repeat kinase 2 (LRRK2) gene has shed new light on genetic variations responsible for autosomal dominantly inherited Parkinson's disease. In this analysis, the most comprehensive published so far, we screened a second large series comprising 53 families with Parkinson's disease for mutations in the LRRK2 gene by direct sequencing to further determine the frequency of the mutation and evaluate the clinical phenotype to establish a genotype/phenotype relation. For comparison, all novel and known mutations were investigated in a cohort of 337 patients with apparently sporadic Parkinson's disease and a cohort of 1200 control subjects using an ABI 7900 Allelic Detection system. We identified 7 more families with LRRK2 variations in the 53 families with Parkinson's disease. Four of these are novel amino acid substitutions (R793M, Q930R, S1096C, S1228T). Because of incomplete penetrance and possible phenocopies pathogenic relevance of the Q930R and S1096C mutations as well as for the previously described A3342G splice site mutation could not be established with certainty. The so far most common mutation (G2019) was not detected in our large cohort. Late onset and typical l-dopa responsive parkinsonian features were generally observed, often accompanied by impairment of executive functions and high interference values in neuropsychological testing, as well as sleeping disturbances but rare hallucinations. There were no abnormalities in electrophysiological investigations. Distinct intrafamily and interfamily differences could be observed, including the clinical presentation of diffuse Lewy body disease in one patient. The frequent finding of cerebral atrophy on MRI and less substantia nigra hyperechogenicity compared with idiopathic Parkinson's disease on transcranial ultrasound needs to be confirmed in further studies. Together with the findings obtained in 46 families in our first study, LRRK2 mutations, therefore, account for 13% of apparently autosomal dominant families in our population with varying but still generally typical clinical presentation of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Self-citationCloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
FRONTO-STRIATAL COGNITIVE DEFICITS AT DIFFERENT STAGES OF PARKINSON'S DISEASE
OWEN, A. M., JAMES, M., LEIGH, P. N., SUMMERS, B. A., MARSDEN, C. D., QUINN, N. P., LANGE, K. W., & ROBBINS, T. W. (1992) · Brain · doi:10.1093/brain/115.6.1727 · Cited by 868
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
(2004) · doi:10.1002/ana.10846 · Cited by 614
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
Self-citationA frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Owen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychologia · doi:10.1016/0028-3932(94)00098-a · Cited by 525
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
The Nighttime Problems of Parkinsonʼs Disease
Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198812000-00004 · Cited by 444
Berg, D., Roggendorf, W., Schröder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 377
Self-citationEchogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
Berg, D., Siefker, C., & Becker, G. (2001) · Journal of Neurology · doi:10.1007/s004150170114 · Cited by 304
Self-citationChip-based genotyping by mass spectrometry
Tang, K., Fu, D.-J., Julien, D., Braun, A., Cantor, C. R., & Köster, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10016 · Cited by 286
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
Wszolek, Z. K., Pfeiffer, R. F., Tsuboi, Y., Uitti, R. J., McComb, R. D., Stoessl, A. J., Strongosky, A. J., Zimprich, A., Müller-Myhsok, B., Farrer, M. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000125015.06989.db · Cited by 266
Self-citationAn LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Sleep disorders in Parkinson's disease
Kumar, S., Bhatia, M., & Behari, M. (2002) · Movement Disorders · doi:10.1002/mds.10167 · Cited by 258
Zimprich, A., Müller-Myhsok, B., Farrer, M., Leitner, P., Sharma, M., Hulihan, M., Lockhart, P., Strongosky, A., Kachergus, J., Calne, D. B., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380647 · Cited by 220
Self-citationClinical features of LRRK2‐associated Parkinson's disease in central Norway
Aasly, J. O., Toft, M., Fernandez‐Mata, I., Kachergus, J., Hulihan, M., White, L. R., & Farrer, M. (2005) · Annals of Neurology · doi:10.1002/ana.20456 · Cited by 191
Iron accumulation in the substantia nigra in rats visualized by ultrasound
Berg, D., Grote, C., Rausch, W.-D., Mäurer, M., Wesemann, W., Riederer, P., & Becker, G. (1999) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(99)00046-0 · Cited by 165
Self-citationFamilial aggregation of Parkinson’s disease: A population-based case-control study in Europe
Elbaz, A., Grigoletto, F., Baldereschi, M., Breteler, M. M. B., Manubens-Bertran, J. M., Pousa, S. L., Dartigues, J.-F., Alpérovitch, A., Tzourio, C., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.9.1876 · Cited by 158
Walter, U., Wittstock, M., Benecke, R., & Dressler, D. W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200015 · Cited by 149
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2
Hernandez, D. G., Paisán‐Ruiz, C., McInerney-Leo, A. M., Jain, S., Meyer‐Lindenberg, A., Evans, E. W., Berman, K. F., Johnson, J. O., Auburger, G. W. J., Schäffer, A. A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20401 · Cited by 116
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Familial basilar migraine associated with a new mutation in the ATP1A2 gene
Ambrosini, A., D’Onofrio, M., Grieco, G., Mambro, A. D., Montagna, G., Fortini, D., Nicoletti, F., Nappi, G., Sances, G., Schoenen, J. E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187072.71931.c0 · Cited by 98
Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation
Deng, H., Le, W., Guo, Y., Hunter, C., Xie, W., & Jankovic, J. J. (2005) · Annals of Neurology · doi:10.1002/ana.20510 · Cited by 82
Riechprüfung mit "sniffin' sticks" zur klinischen Diagnostik des Morbus Parkinson
Daum, R. F., Sekinger, B., Kobal, G., & Lang, C. J. G. (2000) · Der Nervenarzt · doi:10.1007/s001150050640 · Cited by 68
Familial Parkinson's disease: Clinical and genetic analysis of four Basque families
Paisán‐Ruiz, C., Sáenz, A., de Munaín, A. L., Martí, I., Gil, A. M., Martí-Massó, J. F., & Pérez‐Tur, J. (2005) · Annals of Neurology · doi:10.1002/ana.20391 · Cited by 64
LRRK2 mutations and Parkinsonism
Albrecht, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74810-8 · Cited by 56
Szilvássy, Z., Csont, T., Páli, T., Droy‐Lefaix, M., & Ferdinandy, P. (2001) · Journal of Vascular Research · doi:10.1159/000051028 · Cited by 48
LRRK2 mutations and Parkinsonism
Toft, M., Mata, I. F., Kachergus, J. M., Ross, O. A., & Farrer, M. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74809-1 · Cited by 31
Cited by
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl471 · Cited by 533
Reinhardt, P., Schmid, B., Burbulla, L. F., Schöndorf, D. C., Wagner, L., Glatza, M., Höing, S., Hargus, G., Heck, S. A., Dhingra, A., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.008 · Cited by 502
Self-citation
Metadata
- Authors
- Berg, D., Schweitzer, K. J., Leitner, P., Zimprich, A., Lichtner, P., Belcredi, P., Brüssel, T., Schulte, C., Maass, S., Nägele, T., Wszolek, Z. K., & Gasser, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-26
- Volume
- 128
- Issue
- 12
- Pages
- 3000-3011
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2116200652
- Cited by
- 261
- References
- 37
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.